𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A phase II study of 5-fluorouracil plus folinic acid in malignant gliomas in adults

✍ Scribed by D. J. Stewart; Simone Dahrouge; Kathy Soltys

Publisher
Springer US
Year
1995
Tongue
English
Weight
300 KB
Volume
23
Category
Article
ISSN
0167-594X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Phase II trial of irinotecan plus celeco
Phase II trial of irinotecan plus celecoxib in adults with recurrent malignant glioma
✍ David A. Reardon; Jennifer A. Quinn; James Vredenburgh; Jeremy N. Rich; Sridhara πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 219 KB

## Abstract ## BACKGROUND In the current study, the authors report a Phase II trial of irinotecan (CPT‐11), a topoisomerase I inhibitor active against malignant glioma (MG), with celecoxib, a selective COX‐2 inhibitor, among MG patients with recurrent disease. ## METHODS Patients with MG at any

Stereotaxic implantation of 5-fluorourac
Stereotaxic implantation of 5-fluorouracil-releasing microspheres in malignant glioma : A Phase I study
✍ Philippe Menei; Eric Jadaud; Nathalie Faisant; MichΓ¨le Boisdron-Celle; Sophie Mi πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 200 KB

## Abstract ## BACKGROUND The authors developed a new method of drug delivery into the brain using implantable, biodegradable microspheres. The strategy was evaluated initially to provide localized and sustained delivery of the radiosensitizer 5‐fluorouracil (5‐FU) after patients underwent surgica

Effect of HECNU in malignant supratentor
Effect of HECNU in malignant supratentorial gliomas β€” a phase II study
✍ P. Georges; S. Przedborski; J. Brotchi; M. Chatel; D. GΓ©douin; J. Hildebrand πŸ“‚ Article πŸ“… 1988 πŸ› Springer US 🌐 English βš– 453 KB

Forty adults with recurring brain gliomas were treated with HECNU 130 mg/m 2, given i.v. every 5 to 6 weeks (mean 5.4) and corticosteroids. According to the response to treatment, patients were divided in 3 groups: 1. Group I included 8 pts (20%) with objective remission, defined as a clear-cut clin

Phase II study of 5-fluorouracil and fol
Phase II study of 5-fluorouracil and folinic acid in the treatment of patients with advanced gastric cancer: A Southwest Oncology Group study
✍ Giuseppe Colucci πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 71 KB πŸ‘ 3 views

n the article published in Cancer entitled "Phase I1 study of 5-fluoro-I uracil and folinic acid in the treatment of patients with advanced gastric cancer. A Southwest Oncology Group Study,"' the authors erroneously quoted the results of our study and we request a correction. In the results of our